Seeking Alpha
01 Jul 2026, 01:40 UTC · 12w ago
Verdict
Headline takes no side. We score LGND +0.90 across two claims — strongly bullish.
+0.90strongly bullish
More positive than 95% of ticker scores this week
What the story claims
2 claims · scored −1 bearish … +1 bullish
Ligand Pharmaceuticals has completed a significant acquisition of Xoma.
More positive than 77% of claims this week
Ligand Pharmaceuticals' stock price has risen from approximately $86 to nearly $300 over six years.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
More positive than 42% of claims this week
Which stocks this story touches
More positive than 95% of ticker scores this week
The company has delivered exceptional long-term returns and is making strategic portfolio advancements.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
WSJ
4h ago
−5.6%
Price is moving against the score
$298.41 vs $316.09 close before publication (Jun 30) · not market-adjusted
LGND chart →
